Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial

Autor: Oda, Yoshiaki, Kumagai, Yuji, Kanai, Manabu, Iwama, Yasuhiro, Okura, Iori, Minamida, Takeshi, Yagi, Yukihiro, Kurosawa, Toru, Greener, Benjamin, Zhang, Ye, Walson, Judd L *
Zdroj: In The Lancet Infectious Diseases April 2024 24(4):351-360
Databáze: ScienceDirect